您好!欢迎访问洛阳富道生物科技有限公司官方网站!
富道生物耗材
专注高端生物耗材
助力全球生命科学发展
咨询电话
400-160-1996
您现在的位置: 首页 » 新闻动态 » 行业新闻 » 正文
胃肠癌诊断后克罗恩病管理的挑战
发表日期:2022-03-25

Challenges in Crohn’s Disease Management after Gastrointestinal Cancer Diagnosis

胃肠癌诊断后克罗恩病管理的挑战

Crohn’s disease (CD) is a chronic inflammatory bowel disease affecting both young and elderly patients, involving the entire gastrointestinal tract from the mouth to anus. The chronic transmural inflammation can lead to several complications, among which gastrointestinal cancers represent one of the most life-threatening, with a higher risk of onset as compared to the general population. Moreover, diagnostic and therapeutic strategies in this subset of patients still represent a significant challenge for physicians. Thus, the aim of this review is to provide a comprehensive overview of the current evidence for an adequate diagnostic pathway and medical and surgical management of CD patients after gastrointestinal cancer onset.

克罗恩病 (CD) 是一种影响年轻和老年患者的慢性炎症性肠病,涉及从口腔到肛门的整个胃肠道。慢性透壁炎症可导致多种并发症,其中胃肠道癌症是最危及生命的癌症之一,与一般人群相比,发病风险更高。此外,这部分患者的诊断和治疗策略仍然是医生面临的重大挑战。因此,本综述的目的是全面概述目前的证据,以便在胃肠道癌症发作后对 CD 患者进行适当的诊断途径以及内科和外科治疗。

三角细胞摇瓶

三角细胞摇瓶

Crohn’s disease (CD) is a chronic inflammatory bowel disease with a progressive course, potentially affecting the entire gastrointestinal tract from mouth to anus. Several studies have shown an increased risk of both intestinal and extra-intestinal cancer in patients with CD, due to long-standing transmural inflammation and damage accumulation. The similarity of symptoms among CD, its related complications and the de novo onset of gastrointestinal cancer raises difficulties in the differential diagnosis. In addition, once a cancer diagnosis in CD patients is made, selecting the appropriate treatment can be particularly challenging. Indeed, both surgical and oncological treatments are not always the same as that of the general population, due to the inflammatory context of the gastrointestinal tract and the potential exacerbation of gastrointestinal symptoms of patients with CD; moreover, the overlap of the neoplastic disease could lead to adjustments in the pharmacological treatment of the underlying CD, especially with regard to immunosuppressive drugs. For these reasons, a case-by-case analysis in a multidisciplinary approach is often appropriate for the best diagnostic and therapeutic evaluation of patients with CD after gastrointestinal cancer onset.

克罗恩病 (CD) 是一种慢性炎症性肠病,具有进行性病程,可能影响从口腔到肛门的整个胃肠道。几项研究表明,由于长期的透壁炎症和损伤积累,CD 患者患肠癌和肠外癌的风险增加。CD、其相关并发症和胃肠癌的新发症状之间的相似性增加了鉴别诊断的困难。此外,一旦对 CD 患者进行了癌症诊断,选择合适的治疗方法尤其具有挑战性。事实上,手术和肿瘤治疗并不总是与普通人群相同,由于胃肠道的炎症环境和 CD 患者胃肠道症状的潜在恶化;此外,肿瘤疾病的重叠可能导致潜在 CD 的药物治疗调整,尤其是在免疫抑制药物方面。由于这些原因,多学科方法中的个案分析通常适用于对胃肠道癌发病后 CD 患者的最佳诊断和治疗评估。

细胞转瓶

细胞转瓶

The diagnosis and treatment of gastrointestinal cancers in CD patients still represent a relevant challenge. An adequate evaluation of the risk factors, ad hoc surveillance and choosing the most appropriate treatment strategy are key factors for the long-term outcomes of these patients. This further underlines the importance of multidisciplinary management in such a challenging clinical condition. Further studies, in a randomized setting and involving a large sample size, are still needed to better define the best diagnostic and treatment pathways.

细胞培养板

细胞培养板

CD患者胃肠道癌症的诊断和治疗仍然是一个相关的挑战。对风险因素的充分评估、特别监测和选择最合适的治疗策略是这些患者长期预后的关键因素。这进一步强调了在如此具有挑战性的临床条件下多学科管理的重要性。仍然需要在随机环境中并涉及大样本量的进一步研究,以更好地确定最佳诊断和治疗途径。

关键词: 克罗恩病,结直肠癌,小肠癌,肛门癌,多学科方法, Crohn’s disease, colorectal cancersmall bowel cancer,anal cancer,multidisciplinary approach,Show Figures

来源:MDPI https://www.mdpi.com/2072-6694/13/3/574/htm


推荐产品
网站首页 细胞培养耗材 细胞工厂 细胞摇瓶 SUS一次性耗材 关于富道 联系我们
首页 电话 联系